Robert Ettlin

Head of Preclinical Safety at RocketVax

Dr. Robert Ettlin is the Head of Preclinical Safety in Swiss Rockets. After some years in toxicological pathology at F. Hoffmann La Roche Ltd., Ettlin joined Sandoz Ltd. in Basel, where he advanced to Head of Toxicology and later Head of Development Operations Switzerland. In between, he served as Head of Preclinical Development and member of the Executive Committee of Novartis Pharma in Japan.


Org chart


Teams


Offices

This person is not in any offices


RocketVax

RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.


Headquarters

Basel, Switzerland

Employees

11-50

Links